Oteseconazole

Short Description:

API’s Name Indication Innovator Patent Expiry Date(The U.S)
Oteseconazole Reduce the incidence rate of

recurrent vulvovaginal candidiasis

MycoviaPharmaceuticals  Apr.22,2031


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us